Literature DB >> 24850559

False-positive tuberculous meningitis due to laboratory contamination: importance of a holistic clinical evaluation.

Saraschandra Vallabhajosyula1, Renuga Vivekanandan2, Edward A Horowitz2.   

Abstract

Incidence of tuberculosis in Nebraska is 1.9/100,000 people. Tuberculous meningitis is rare and comprises 1% of extrapulmonary tuberculosis. An elderly Caucasian man presented with fever, headache, altered mentation and a history of tick bite. Cerebrospinal fluid (CSF) analysis showed negative cultures and the patient was treated empirically for tickborne illness. Forty-five days later, CSF nucleic acid amplification test (NAAT) was positive for tuberculosis. On readmission, repeat neurological examination and CSF analysis were benign and the patient was not offered antituberculous treatment. Genotype investigation of the culture and NAAT specimen by the Center for Disease Control confirmed laboratory contamination. The literature reports an incidence of 2-4% for false-positive tuberculosis cultures. Contaminated devices, clerical errors and laboratory errors have been implicated. Laboratory contamination results in smear-negative culture-positive cases. Epidemiological investigation with genotype testing is confirmatory. Detailed clinical assessment with good clinical and laboratory communication and frequent laboratory surveillance is advocated to mitigate these cases. 2014 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Year:  2014        PMID: 24850559      PMCID: PMC4039959          DOI: 10.1136/bcr-2014-204359

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  15 in total

Review 1.  Review of false-positive cultures for Mycobacterium tuberculosis and recommendations for avoiding unnecessary treatment.

Authors:  W J Burman; R R Reves
Journal:  Clin Infect Dis       Date:  2000-11-17       Impact factor: 9.079

2.  Dedicated decontamination: A necessity to prevent cross contamination in high throughput mycobacteriology laboratories.

Authors:  C Rodrigues; D Almeida; S Shenai; N Goyal; A Mehta
Journal:  Indian J Med Microbiol       Date:  2007-01       Impact factor: 0.985

3.  Laboratory cross-contamination of Mycobacterium tuberculosis: an investigation and analysis of causes and consequences.

Authors:  M Poynten; D N Andresen; T Gottlieb
Journal:  Intern Med J       Date:  2002-11       Impact factor: 2.048

4.  Recognizing laboratory cross-contamination: two false-positive cultures of Mycobacterium tuberculosis--Oklahoma, 2011.

Authors:  Matthew G Johnson; Phillip H Lindsey; Charles F Harvey; Kristy K Bradley
Journal:  Chest       Date:  2013-07       Impact factor: 9.410

5.  Investigation of suspected laboratory cross-contamination: interpretation of single smear-negative, positive cultures for Mycobacterium tuberculosis.

Authors:  V J Cook; G Stark; D L Roscoe; A Kwong; R K Elwood
Journal:  Clin Microbiol Infect       Date:  2006-10       Impact factor: 8.067

6.  Estimated costs of false laboratory diagnoses of tuberculosis in three patients.

Authors:  Jill M Northrup; Ann C Miller; Edward Nardell; Sharon Sharnprapai; Sue Etkind; Jeffrey Driscoll; Michael McGarry; Harry W Taber; Paul Elvin; Noreen L Qualls; Christopher R Braden
Journal:  Emerg Infect Dis       Date:  2002-11       Impact factor: 6.883

7.  Investigation of Laboratory cross-contamination of Mycobacterium tuberculosis cultures.

Authors:  L Fitzpatrick; C Braden; W Cronin; J English; E Campbell; S Valway; I Onorato
Journal:  Clin Infect Dis       Date:  2004-02-27       Impact factor: 9.079

8.  The PCR-Based Diagnosis of Central Nervous System Tuberculosis: Up to Date.

Authors:  Teruyuki Takahashi; Masato Tamura; Toshiaki Takasu
Journal:  Tuberc Res Treat       Date:  2012-05-13

9.  Rapid detection of laboratory cross-contamination with Mycobacterium tuberculosis using multispacer sequence typing.

Authors:  Zoheira Djelouadji; Jean Orehek; Michel Drancourt
Journal:  BMC Microbiol       Date:  2009-03-03       Impact factor: 3.605

10.  Optimized molecular resolution of cross-contamination alerts in clinical mycobacteriology laboratories.

Authors:  Ana Martín; Marta Herranz; Miguel Martínez Lirola; Rosa Fernández Fernández; Emilio Bouza; Darío García de Viedma
Journal:  BMC Microbiol       Date:  2008-02-14       Impact factor: 3.605

View more
  1 in total

1.  Triplicate Sputum Cultures for Efficacy Evaluation of Novel Antituberculosis Regimens.

Authors:  Andreas H Diacon; Elana van Brakel; Nacer Lounis; Paul Meyvisch; Ben Van Baelen; Tine De Marez; Eilidh Jenkins; Brian Dannemann
Journal:  Am J Respir Crit Care Med       Date:  2017-12-15       Impact factor: 21.405

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.